In 2024, Sweden leads the use of respiratory system medicine in Europe with 239.7 units per thousand persons per day, followed by Slovakia at 123.6 units and the Netherlands at 110.8 units. Estonia and Iceland also register high levels at 109.6 and 102 units respectively. At the lower end, Latvia shows the least usage at 53.5 units. In 2023, Sweden saw a significant increase of 4.3%, while Slovakia experienced a slight decline of 0.57%. Estonia and Croatia exhibited notable growth rates, with Estonia increasing by 3.14% and Croatia by 1.64%. Over the last five years, the Compound Annual Growth Rate (CAGR) suggests steady but varied usage trends among these countries.
Future trends to watch include potential shifts in respiratory system medicine use due to emerging health policies, changes in population demographics, and advancements in medical therapies. Additionally, environmental factors and increasing air pollution levels may drive higher usage rates across Europe. Monitoring these elements will be crucial for understanding and anticipating the demand for respiratory system medicine in different European countries.
Top countries in Respiratory System Medicine Use by Country
| # | 9 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Sweden | 239.7 | 2023 | +3.72% | +4.3% | View data |
| 2 | 2 Slovakia | 123.6 | 2023 | +0.16% | -0.57% | View data |
| 3 | 3 Netherlands | 110.8 | 2023 | +0.45% | -0.072% | View data |
| 4 | 4 Estonia | 109.6 | 2023 | -2.75% | +3.14% | View data |
| 5 | 5 Iceland | 102 | 2023 | -0.78% | +1.63% | View data |
| 6 | 6 Portugal | 97.6 | 2023 | -1.31% | +0.082% | View data |
| 7 | 7 Croatia | 76.6 | 2023 | +1.86% | +1.64% | View data |
| 8 | 8 France | 68.8 | 2023 | 0% | +0.18% | View data |
| 9 | 9 Latvia | 53.5 | 2023 | -14.26% | +1.24% | View data |
